STOCKWATCH
·
Healthcare Research- Analytics & Technology
New Launch24 Feb 2025, 04:21 pm

Indegene Launches Cortex, A Fit-For-Purpose Generative Al Platform, Verticalized For The Life Sciences Industry

AI Summary

Indegene, a digital-first, life sciences commercialization company, launched Cortex, a fit-for-purpose Generative Al (GenAl) platform, verticalized for the life sciences industry. This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain, making medical writing more effective and efficient, and accelerating Medical-Legal-Regulatory (MLR) reviews. Its knowledge engineering interface codifies Indegene’s 25+ years of subject matter expertise into advanced knowledge graphs using a domain-friendly interface. Moreover, its fit-for-purpose agents can be configured with any preferred Large Language Model (LLM) and evolve as LLM state-of-the-art improves. Further, its multi-agent orchestration enables use case-specific applications for enterprise-wide system integration. Together, these yield more reliable, accurate and trustworthy outcomes from LLM-based agents with substantially faster turnaround times and better ROI at lower risk, relative to industry-agnostic platforms.

Key Highlights

  • Indegene launched Cortex, a fit-for-purpose Generative Al platform verticalized for the life sciences industry
  • Cortex enables life sciences leaders to adopt and scale transformative technology with enterprise-grade governance
  • Knowledge engineering interface codifies Indegene’s 25+ years of subject matter expertise into advanced knowledge graphs
  • Fit-for-purpose agents can be configured with any preferred Large Language Model (LLM) and evolve as LLM state-of-the-art improves
  • Multi-agent orchestration enables use case-specific applications for enterprise-wide system integration
INDGN
Healthcare Research- Analytics & Technology
Indegene Ltd

Price Impact